Cipher Pharmaceuticals Inc. (TSX:CPH)
Canada · Delayed Price · Currency is CAD 17.99
+0.44 (2.51%)
Aug 10, 2026, 3:59 PM EST
Cipher Pharmaceuticals Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Operating Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | 30.87 | 27.33 | 11.55 | 20.38 | 26.64 | 7.76 |
Depreciation & Amortization | 7.22 | 7.23 | 4.02 | 1.23 | 0.99 | 0.7 |
Stock-Based Compensation | 1.8 | 1.74 | 1.07 | 1.19 | 0.4 | 0.14 |
Other Adjustments | -11.5 | -11.8 | -6.04 | -3.53 | -14.27 | 0.54 |
Change in Receivables | 2.02 | 2.65 | -8.77 | 1.71 | -0.14 | 2.56 |
Changes in Inventories | -2.66 | -2.4 | 3.6 | -0.83 | -0.5 | -0.76 |
Changes in Accounts Payable | 1.2 | 0.52 | 1.28 | 0.53 | -1.45 | -1.23 |
Changes in Income Taxes Payable | - | -0.05 | 0.05 | -4.97 | -0.85 | 3.59 |
Changes in Unearned Revenue | 1.95 | 5.02 | 12.79 | 0.27 | -0.19 | 0.14 |
Changes in Other Operating Activities | -0.63 | -0.52 | 0.01 | 0.01 | 0.1 | 0.37 |
Operating Cash Flow | 30.03 | 29.73 | 19.55 | 16 | 10.73 | 13.81 |
Operating Cash Flow Growth | 40.77% | 52.08% | 22.17% | 49.18% | -22.36% | 18.16% |
Investing Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Capital Expenditures | -0.03 | -0.03 | -0.04 | -0.02 | -0.08 | - |
Sale of Property, Plant & Equipment | - | 0.13 | - | - | - | - |
Purchases of Intangible Assets | - | -0.17 | - | - | - | - |
Cash Acquisitions | - | - | -80 | -0.12 | - | - |
Investing Cash Flow | -0.56 | -0.07 | -80.04 | -0.14 | -0.08 | - |
Financing Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Long-Term Debt Issued | - | -35 | 40 | - | - | - |
Long-Term Debt Repaid | -5 | - | - | - | - | - |
Net Long-Term Debt Issued (Repaid) | -5 | -35 | 40 | - | - | - |
Issuance of Common Stock | 0.22 | 0.22 | 0.15 | 0.43 | 0.13 | 0.08 |
Repurchase of Common Stock | - | -5.38 | -0.18 | -5.56 | -1.99 | -1.72 |
Net Common Stock Issued (Repurchased) | 0.22 | -5.17 | -0.02 | -5.13 | -1.86 | -1.64 |
Other Financing Activities | -0.31 | -0.31 | -0.68 | -0.11 | -0.06 | -0.83 |
Financing Cash Flow | -45.47 | -40.47 | 39.3 | -5.24 | -1.91 | -2.47 |
Net Cash Flow
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Foreign Exchange Rate Adjustments | 0.41 | 0.47 | -0.79 | 0.38 | -0.44 | 0.06 |
Net Cash Flow | -16 | -10.82 | -21.2 | 10.61 | 8.73 | 11.34 |
Free Cash Flow
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | 30 | 29.7 | 19.5 | 15.98 | 10.64 | 13.81 |
Free Cash Flow Growth | 40.90% | 52.28% | 22.05% | 50.11% | -22.95% | 18.26% |
FCF Margin | 58.90% | 58.87% | 58.45% | 75.50% | 51.48% | 62.95% |
Free Cash Flow Per Share | 1.15 | 1.14 | 0.77 | 0.63 | 0.41 | 0.51 |
Levered Free Cash Flow | 32.91 | 1.98 | 73.24 | 16.6 | 24.65 | 10.58 |
Unlevered Free Cash Flow | 37.29 | 36.15 | 41.75 | 12.34 | 23.66 | 11.1 |